AstraZeneca
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.www.astrazeneca.com
496
MENTIONS
281
EPISODES
228
PODCASTS
Search complete. 496 mentions across 281 episodes found for "AstraZeneca".
Oct 28, 2026
Alex MercerHOST
In Europe, there's a decision in breast cancer.
Alex MercerHOST
The EU has approved AstraZeneca and Daiichi Sankyo's Enher2, a HER2-directed antibody drug conjugate, for use after surgery.
Alex MercerHOST
It covers adults whose HER2-positive early breast cancer showed residual invasive disease at surgery after pre-surgery treatment with a taxane and HER2-targeted therapy.
Alex MercerHOST
The approval rests on Phase III results reported previously.
Alex MercerHOST
AstraZeneca says this is Inher2's first EU approval in the curative intent early breast cancer setting.
Maya PatelHOST
Turning to neuroscience and neuromuscular disease.
Maya PatelHOST
Novartis' third-quarter report shows it has discontinued the Phase 3 program for remabrutinib, an oral BTK inhibitor, in generalized myasthenia gravis.
Jeff AxtHOST
So we may hear more about what's going on with that latest death in the multiple sclerosis trial.
Jeff AxtHOST
We'll also hear from AstraZeneca, Merck, GSK, and Eli Lilly.
Jeff AxtHOST
So Eli Lilly is a great segue to that M&A analysis.
Jeff AxtHOST
We know they're one of our biggest spenders this year.
Garth DelikanGUEST
And if you do, nothing bad ever comes towards you.
Garth DelikanGUEST
And I had another lady there who worked for AstraZeneca, a huge pharmaceutical company, who said, I love what you talked about on confidence building.
Garth DelikanGUEST
Can you come and do a talk on confidence building? So, of course, being ever the entrepreneur, I said, yes, of course I can.
Garth DelikanGUEST
So I put together a workshop on confidence building, delivered that.
Jim CramerHOST
I asked it, her, whoever, to tell me which companies have the most drugs in front of the FDA for an up-or-down decision.
Jim CramerHOST
It came up with AstraZeneca and Novartis, two European pharma giants.
Jim CramerHOST
It knows how to count.
Jim CramerHOST
My team and I then queried what the drugs did, and we asked Claude what Wall Street thought the sales potential were for these drugs.
Jim CramerHOST
We then retrieved company-published filings and then went into a deep dive of each drug to see if the analysts liked them and thought they would be green-lighted.
Jim CramerHOST
By the time I was finished, the research clearly favored the AstraZeneca pipeline over Novartis, which was second, and then the others were all just the third.
Jim CramerHOST
And that's the point where I would normally begin to do my deep dive about what these drugs could do.
Jim CramerHOST
I purposely did not use any of the bots for information on this because they would involve subjective decisions about how the medicines would do and who is pushing for them.
Mati GillGUEST
I have the fortune of being the CEO, the founding CEO of Ion Labs.
Mati GillGUEST
Island Labs, as you mentioned, is a unique coalition where we brought together four pharma companies, Pfizer, AstraZeneca, Merck from Germany, and Teva, together with Amazon Web Services, venture capital firms, and supported by the Israeli government, by the Israel Innovation Authority as a public-private partnership.
Mati GillGUEST
My personal journey, I'm originally American, moved to Israel a few decades ago as a kid.
Mati GillGUEST
and have been living in Israel ever since.
Jerry MillerHOST
There's so many layers.
Jerry MillerHOST
Like, are these good jobs? Are these high-dollar jobs? Are these jobs that are going to lead gentrification? What's this do to housing in Charlottesville? Are they jobs that are going to stay? What's this do to central Virginia? What's this do to pushing people to Greene County, Louisa County, Fluvanna County? Does this make Charlottesville and Amaral County more white, wealthy, and homogenous? What's this do to development? What's this do to the student body at the University of Virginia? How will this be compounded, this trend by biotechnology, AstraZeneca in this beltway that's coming here?
Judah WitcoverHOST
That's the kind of story I wanna talk about on the show.
Judah WitcoverHOST
I
15 MINS LATER
Jerry MillerHOST
There's no coincidence, right, that a $100 million donation to a biotechnology school is a mere couple miles away from a $100 plus million project that's bringing 275 apartments and how many hotels, Judah? How many hotel rooms? 133 rooms.
Jerry MillerHOST
They're within a few miles of each other.
Jerry MillerHOST
And then a little further, but not really down that far down the pipe is AstraZeneca's 600 plus jobs at a starting wage of 125 K. Yeah.
Jerry MillerHOST
And all the hanger on jobs and companies that are birthed and launched.
Gregor WillhauckGUEST
And that part of the business was then acquired by Tremble.
Gregor WillhauckGUEST
The life science part went on for a couple of years more and was finally acquired by AstraZeneca.
Gregor WillhauckGUEST
So overall, a pretty good story.
Michal GulaHOST
Startups are usually very, very lucky if they get one exit and you actually got two
Gregor WillhauckGUEST
And that part of the business was then acquired by Tremble.
Gregor WillhauckGUEST
The life science part went on for a couple of years more and was finally acquired by AstraZeneca.
Gregor WillhauckGUEST
So overall, a pretty good story.
Michal GulaHOST
Startups are usually very, very lucky if they get one exit and you actually got two
Angus DalgleishGUEST
But it was when we realized that the cancers were nearly all associated with the new messenger RNA ones.
Angus DalgleishGUEST
Indeed, the messenger RNA ones are universally the only ones used in this country for the boosters, because AstraZeneca, realizing the extreme damage caused by their vaccine in clots and strokes, and with 48,000 yellow cards sitting on the MHRA that they do absolutely nothing about.
Angus DalgleishGUEST
realized that there would be reputational damage so they withdrew it they didn't wait for it to be banned which they should have banned ages ago the regulatory authority the mhra failed abysmally in controlling this but that's something we could go back to but with regards to the cancer we suddenly realized it was the messenger rna and then these people who's had some very aggressive cancers The surgeons had sent the tumor off to have a look at what was actually in the tumor.
Angus DalgleishGUEST
And from America and Europe, they found that they had the spike protein actually inserted in the cancer.
Jerry MillerHOST
Not only is it a 60-hour-a-week Charlottesville and Albemarle County, it might now be a 65-hour-a-week Charlottesville and Albemarle County.
Jerry MillerHOST
And if you live in Louisa or Greene County, with what biotechnology is going to do at AstraZeneca and Eli Lilly, Louisa and Greene, albeit that's in Goochland, Okay, but still close proximity to Louisa.
Jerry MillerHOST
Louisa and Green, I'm going to make the comment, are now 55-hour-a-week towns.
Jerry MillerHOST
You're at 65 if you want to live in Charlottesville and Albemarle.
271 more episodes mention AstraZeneca.
Create an account to see the whole feed, search across every transcript, and follow the entities you care about.